Deep Immunomics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

April 29, 2021 April 29, 2021 | Illumina joins the Gates Foundation in a global pathogen genomics initiative, new money for immune profiling, and Benchling nets $200M for their cloud platform.   $375M: Fund for Growth-Stage Medtech, Digital Health  Endeavour Vision has closed Endeavour Medtech Growth II (EMG II) LP at USD 375 million in capital commitments. The fund will pursue the same strategy as its predecessor: to support growth-stage medtech and digital health innovations that advance the standard of care and bring efficiencies to healthcare systems. Both new and returning...

Immunomics firm reels in $14m to advance drug discovery ImmunoScape plans to use the investor funds to grow its Asia presence, expand into the US, and to further develop its Deep Immunomics platform technology. ImmunoScape, a biotech firm whose offerings include an immunomics-based technology platform designed to provide novel insights into the human immune system, has sealed up a $14m USD fundraising round. The infusion of investor cash brings the company’s total funding over the course of the past year to $25m USD. According to the company, the money will be us...

Singaporean startup ImmunoScape raises $14M to advance capabilities Singaporean startup ImmunoScape raises $14M to advance capabilities 19 April 2021 | News Round is co-led by EDBI, Anzu Partners and UTEC, representing major biotech innovation centers across the U.S., Singapore and Japan Image credit- shutterstock.com ImmunoScape, a Singapore headquartered biotech company with an immunomics-based technology platform that provides novel insights into the human immune system, has announced it has completed a $14 million fundraising round led by existing investors Anzu Partners, Univ...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Immunoscape forms scientific advisory board of distinguished immunology experts 29 Jan 2021 / 19:30 H. Pix for representational purpose only. KUALA LUMPUR: Biotech company, ImmunoScape has announced the formation of its Scientific Advisory Board (SAB) comprising leading scientists in immunology and oncology who will help to guide ImmunoScape’s scientific strategy. The founding members of the SAB bring substantial scientific insight and expertise to assist the company, which include Evan Newell, Ph.D.; Philip Greenberg, M.D.; Patrick Reeves, Ph.D.; and, Paul Thomas, Ph.D. “To form thi...